Literature DB >> 26293360

Expanding the Horizons of Nuclear Cardiology: Disease Management.

David Wolinsky.   

Abstract

Mesh:

Substances:

Year:  2015        PMID: 26293360     DOI: 10.1007/s12350-015-0262-9

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


× No keyword cloud information.
  5 in total

1.  Recommendations for (18)F-fluorodeoxyglucose positron emission tomography imaging for cardiac sarcoidosis: Japanese Society of Nuclear Cardiology recommendations.

Authors:  Yoshio Ishida; Keiichiro Yoshinaga; Masao Miyagawa; Masao Moroi; Chisato Kondoh; Keisuke Kiso; Shinichiro Kumita
Journal:  Ann Nucl Med       Date:  2014-01-25       Impact factor: 2.668

2.  Proceedings of the ASNC cardiac PET summit meeting, May 12 2014, Baltimore MD : 4. Novel applications of cardiovascular PET.

Authors:  Ron Blankstein; Justin Lundbye; Gary Heller
Journal:  J Nucl Cardiol       Date:  2015-07-22       Impact factor: 5.952

3.  (99m)Tc-pyrophosphate scintigraphy for differentiating light-chain cardiac amyloidosis from the transthyretin-related familial and senile cardiac amyloidoses.

Authors:  Sabahat Bokhari; Adam Castaño; Ted Pozniakoff; Susan Deslisle; Farhana Latif; Mathew S Maurer
Journal:  Circ Cardiovasc Imaging       Date:  2013-02-11       Impact factor: 7.792

Review 4.  Role of imaging in the diagnosis and management of patients with cardiac amyloidosis: state of the art review and focus on emerging nuclear techniques.

Authors:  Wael A Aljaroudi; Milind Y Desai; W H Wilson Tang; Dermot Phelan; Manuel D Cerqueira; Wael A Jaber
Journal:  J Nucl Cardiol       Date:  2014-04       Impact factor: 5.952

5.  Congestive heart failure and left ventricular dysfunction complicating doxorubicin therapy. Seven-year experience using serial radionuclide angiocardiography.

Authors:  R G Schwartz; W B McKenzie; J Alexander; P Sager; A D'Souza; A Manatunga; P E Schwartz; H J Berger; J Setaro; L Surkin
Journal:  Am J Med       Date:  1987-06       Impact factor: 4.965

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.